89 related articles for article (PubMed ID: 6446397)
21. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
Corser CA; Day GJ; Humble MW
N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of netilmicin.
Hussain Qadri SM; Johnson S
J Okla State Med Assoc; 1984 Jul; 77(7):198-201. PubMed ID: 6432977
[No Abstract] [Full Text] [Related]
23. In vitro evaluation of CM 40876, a new third-generation cephalosporin.
Raimondi A; Cocuzza C; Musmanno G; Mattina R
Chemioterapia; 1987 Jun; 6(2 Suppl):103-6. PubMed ID: 3509932
[No Abstract] [Full Text] [Related]
24. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
25. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
26. Diffusion disk susceptibility testing with cefotaxime.
Aswapokee N; Aswapokee P; Neu HC; Fu KP
Antimicrob Agents Chemother; 1979 Aug; 16(2):164-6. PubMed ID: 114106
[TBL] [Abstract][Full Text] [Related]
27. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
28. The antibacterial activity of thienamycin against multiresistant bacteria-comparison with beta-lactamase stable compounds.
Romagnoli MF; Fu KP; Neu HC
J Antimicrob Chemother; 1980 Sep; 6(5):601-6. PubMed ID: 6967870
[No Abstract] [Full Text] [Related]
29. Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.
Pottumarthy S; Deshpande LM; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):95-9. PubMed ID: 15964496
[TBL] [Abstract][Full Text] [Related]
30. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity.
Cafarelli A; Magliulo E; Piantieri G
G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525
[No Abstract] [Full Text] [Related]
31. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Fasola EL; Fasching CE; Peterson LR
J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases.
Sanders CC
J Chemother; 1996 Feb; 8 Suppl 2():57-62. PubMed ID: 8738847
[TBL] [Abstract][Full Text] [Related]
33. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
Xu W; Chen X
Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
[TBL] [Abstract][Full Text] [Related]
34. Inducing activity of cephalosporins for beta-lactamases in two characterized staphylococcal strains.
Hernádi FJ; Frommer-Filep M; Gál S; Tar A; Koncz A; Toth-Martinez BL
J Chemother; 1989 Jul; 1(4 Suppl):342-4. PubMed ID: 16312430
[No Abstract] [Full Text] [Related]
35. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
Drieux L; Brossier F; Sougakoff W; Jarlier V
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins.
Betriu C; Salso S; Sánchez A; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
Int J Antimicrob Agents; 2006 Jul; 28(1):1-5. PubMed ID: 16769202
[TBL] [Abstract][Full Text] [Related]
37. Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.
Hamilton-Miller JM; Brumfitt W; Reynolds AV
J Antimicrob Chemother; 1978 Sep; 4(5):437-44. PubMed ID: 308505
[No Abstract] [Full Text] [Related]
38. Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases.
Florijn A; Nijssen S; Schmitz FJ; Verhoef J; Fluit AC
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):241-3. PubMed ID: 11957033
[No Abstract] [Full Text] [Related]
39. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
Piantieri G; Cafarelli A; Magliulo E
G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
[No Abstract] [Full Text] [Related]
40. Comparative activity of cefoperazone against selected cephalosporinase-producing enteric bacteria.
Chabbert YA; Collatz E
Clin Ther; 1980; 3(Spec Issue):98-102. PubMed ID: 6446402
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
